The geko™ device has officially been assessed and certified with meeting the requirements of Part II of The Medical Devices Regulations 2002, Annex II (excluding section 4), for: Increased blood circulation, for the prevention of venous thrombosis Prevention of oedema Treatment of venous insufficiency and...
The Department for International Trade (DIT) has named Sky Medical Technology part of their international showcase of UK exporters of innovative MedTech making waves globally. Getting selected has allowed us to represent the UK at key overseas events, including being profiled in DIT campaigns in key...
Five MedTech trends to shape healthcare in 2023 Since the initial COVID-19 outbreaks sent the nation into lockdown three years ago, our healthcare system has been facing disruption while under resourced and tackling backlogs – the waiting list for elective surgery has now reached a record...
Hyponatremia and hypernatremia are medical conditions for imbalanced levels of sodium in the blood. These imbalances can increase the risk of life-threatening blood clots (venous thromboembolisms or ‘VTEs’) in hospital patients, especially the elderly and critically ill undergoing surgery. Hospital acquired VTE is one of the...
Technological advancements like the geko™ device have the potential to usher in a new era in the treatment of venous leg ulcers (VLUs) – a wound on the leg or ankle caused by abnormal or damaged veins. Wounds such as these are common and can...
We recently welcomed Fiona Young as the new director for wound care therapy at Sky Medical Technology! Fiona has joined the team to lead the market adoption of the geko™ device for the healing of leg ulcers – a condition that affects millions of people...
For a medical technology (MedTech) device to be successfully adopted within a healthcare system, it needs to have proof of concept, regulatory approval, and clinical data that shows it enhances the current standard of care or addresses an unmet need. The geko™ device is clinically proven...
This year’s Let’s Talk Clots virtual conference, hosted by Thrombosis UK, as part of World Thrombosis Day, was attended by more than 1,500 healthcare professionals (HCPs) from around the world looking to learn more about developments in thrombosis prevention and care. Over the three-day event, G&N...
Today marks World Thrombosis Day – a day dedicated to raising awareness of blood clots and recognising that this largely misunderstood condition can have severe complications. One in four people die from thrombosis-related conditions every year. In Europe and the US, it kills more people...
Earlier this year, our CEO Bernard Ross joined the Liverpool City Region (LCR) Combined Authority’s Innovation Board to champion early-stage innovations and drive investments helping to accelerate businesses growth and competitiveness across various industry sectors, including Health and Life Sciences. An environment for innovation to thrive LCR’s...